Commercialization Strategy: Why Most Product Launches Fail Before They Start

A commercialization strategy is the structured plan that takes a product, service, or capability from internal readiness to market revenue. It covers pricing, positioning, channel selection, launch sequencing, and the sales and marketing motions required to generate demand at scale. Get it right and you compress the time between launch and profitable growth. Get it wrong and you spend the next 18 months firefighting problems that should have been solved before anyone saw the product.

Most companies treat commercialization as a launch event. It is not. It is a series of interconnected decisions, made in the right order, that determine whether a product earns its place in the market or quietly disappears into the pipeline graveyard.

What Does a Commercialization Strategy Actually Cover?

The term gets used loosely, so it is worth being precise. A commercialization strategy is not your marketing plan, your launch brief, or your product roadmap. It sits above all three. It answers the questions that, if left unanswered, will cause every downstream execution decision to be made on assumption rather than intent.

Those questions are: Who is this for, specifically? What does it replace or displace in their current behaviour? How will we price it and why? Which channels will carry it to market and in what sequence? What does success look like in months one, six, and eighteen? And what are we willing to sacrifice to stay focused?

I have sat in enough product launch meetings to know that most organisations can answer the first question fluently and the rest poorly. They have a persona document, sometimes a beautifully designed one, and almost nothing else that has been genuinely stress-tested. The pricing was set by finance. The channels were inherited from the last product. The success metrics were whatever the board wanted to see in the deck.

That is not a commercialization strategy. That is a set of defaults dressed up as a plan.

If you want to think more rigorously about the broader growth architecture that commercialization sits inside, the Go-To-Market and Growth Strategy hub covers the connected disciplines in depth.

Why Pricing Is the Most Consequential Decision You Will Make

Pricing is where most commercialization strategies reveal their actual quality. It is easy to write a positioning statement. It is much harder to set a price that is simultaneously defensible to your CFO, credible to your buyer, and strategically coherent with where you want the product to sit in the market in three years.

Price is not just a revenue mechanism. It is a signal. A product priced at a significant premium to the market tells buyers something about what category it belongs to, what quality to expect, and who else is buying it. A product priced to drive volume tells a completely different story. Both can be right. Neither is neutral.

BCG’s research on long-tail pricing in B2B markets makes a point that has stuck with me: most businesses systematically undercharge their least price-sensitive customers and overcharge their most price-sensitive ones. The result is margin left on the table at the top end and churn at the bottom. A proper commercialization strategy forces you to segment by price sensitivity, not just by firmographic or demographic profile.

Early in my agency career I watched a client launch a SaaS product at a price point that was clearly set to match a competitor rather than reflect the value they were delivering. Within six months they were discounting to close deals, which destroyed the margin model and, more importantly, signalled to the market that the original price had been aspirational rather than earned. They never fully recovered the pricing integrity. The lesson was not that they priced too high. It was that they priced without a clear rationale, so they had nothing to defend when buyers pushed back.

Channel Selection Is a Strategic Commitment, Not a Tactical Choice

The channels you choose to bring a product to market are not just distribution decisions. They determine your cost structure, your speed of feedback, your brand associations, and your ability to scale. Choosing the wrong channel early is not a mistake you fix in quarter two. It is a structural problem that compounds.

When I was running an agency and we grew from around 20 people to close to 100, a significant part of what drove that growth was being ruthlessly selective about which client categories we pursued and through which channels we built relationships. We did not try to be everywhere. We went deep in the sectors where we had genuine expertise and let the work generate reputation. That is a channel strategy, even if it does not look like one in the traditional marketing sense.

For product businesses, the channel decision is often between direct and indirect, between owned and paid, between high-touch and self-serve. Each comes with trade-offs that are rarely spelled out clearly in launch plans. Direct gives you control and margin but is slow to scale. Indirect gives you reach but dilutes your relationship with the end customer. Paid gives you speed but creates dependency. Owned gives you compounding returns but requires patience and investment before the returns appear.

The creator economy has added a new layer of complexity here. Platforms like Later have documented how creator-led go-to-market strategies can compress the time between product awareness and purchase intent in ways that traditional paid channels cannot replicate. That is not a reason to default to creator partnerships. It is a reason to understand the mechanism and decide deliberately whether it fits your product, your audience, and your margin structure.

The Difference Between Demand Creation and Demand Capture

One of the things I changed my mind about over the course of my career is the relative value of performance marketing versus brand and reach. Earlier on, I overvalued lower-funnel activity. It looked efficient. The attribution was clean. The CPAs were trackable. The problem is that much of what performance marketing gets credited for was going to happen anyway. You are capturing intent that already existed, not creating new demand.

Think about it like a clothes shop. Someone who walks in and tries something on is far more likely to buy than someone who walks past. But the question a commercialization strategy has to answer is: how do you get more people through the door in the first place? That is a reach and awareness problem, not a conversion optimisation problem. And most launch plans I have reviewed spend 80% of their thinking on conversion and almost none on the upstream question of who does not yet know this product exists and why they should care.

Forrester’s intelligent growth model makes a related point about the balance between acquiring new customers and deepening relationships with existing ones. Both matter. But for a new product launch, the sequencing matters enormously. If you spend the first six months optimising for conversion among people who already had some awareness, you are not building a market. You are harvesting a small one.

A strong commercialization strategy explicitly separates the demand creation budget from the demand capture budget and makes a deliberate argument for the ratio between them. Most do not. They lump it all into “marketing spend” and let the channel managers fight it out.

Positioning Is Not a Tagline. It Is a Set of Trade-Offs.

I have judged the Effie Awards, which means I have read hundreds of cases where brands tried to articulate what they stood for and why it drove business results. The cases that hold up are not the ones with the cleverest creative. They are the ones where the positioning was genuinely specific, genuinely differentiated, and genuinely connected to something the target audience cared about enough to change their behaviour.

Positioning is not a description of your product. It is a claim about why your product is the right choice for a specific person in a specific situation, relative to the alternatives they would otherwise consider. That specificity is what makes it useful. And that specificity requires you to make trade-offs: to say this product is not for everyone, to say this is the one thing we are better at than anyone else, to say this is the comparison we want buyers to make.

BCG’s work on biopharma product launches is instructive here even for non-pharma contexts. The discipline required to position a new drug, where the regulatory environment forces precision about indication, patient population, and clinical differentiation, produces sharper positioning than most consumer or B2B launches ever achieve. The lesson is not to import pharma process wholesale. It is to borrow the habit of precision.

Vague positioning is almost always a sign that the internal conversation about trade-offs was never finished. Someone in the room said “but we could also appeal to X” and rather than resolve the tension, the team broadened the positioning to include everyone. The result is a message that resonates with no one strongly enough to drive action.

Launch Sequencing: Why the Order of Decisions Matters

Early in my career, I was at Cybercom and there was a brainstorm for Guinness. The founder had to leave mid-session for a client meeting and handed me the whiteboard pen. My internal reaction was something close to controlled panic. But the experience taught me something that has stayed with me: the person holding the pen has to make decisions, not just facilitate options. You cannot defer every choice. At some point, you have to commit to a direction.

Commercialization strategy has the same dynamic. There is a temptation to keep all options open until the last possible moment, to gather more data, to run one more focus group, to wait for the market to give you a clearer signal. The problem is that the market does not give you a clearer signal until you are in it. And by the time you are in it, the decisions you deferred have been made by default.

Launch sequencing is about deciding what needs to be true before you can do the next thing. Pricing needs to be set before you build your sales compensation model. Positioning needs to be locked before you brief the creative team. Channel selection needs to be confirmed before you allocate budget. These are not arbitrary sequences. They are logical dependencies, and violating them creates rework that is expensive in both time and money.

Agile methodologies have complicated this for some organisations. The argument that you can iterate your way to the right answer is partially true in product development. It is much less true in go-to-market, where your first impression with a customer segment is difficult to revise and where channel relationships take time to build. Forrester’s thinking on agile scaling acknowledges this tension: agility in execution is valuable, but it requires clarity of direction to avoid becoming expensive improvisation.

Measuring Commercialization Success Without False Precision

One of the things I push back on consistently is the idea that a good commercialization strategy requires a perfect measurement framework. It does not. It requires an honest one.

The honest measurement question for a new product launch is not “what is our CAC?” in month one. It is “are we reaching the right people, are they engaging with the product, and are the early signals of retention or repeat behaviour consistent with the model we built?” Those are leading indicators. They tell you whether the strategy is working before the lagging indicators, like revenue and margin, have had time to materialise.

Vidyard’s research on pipeline and revenue potential for GTM teams highlights a recurring problem: organisations measure what is easy to measure rather than what is strategically important. The result is that teams optimise for metrics that look good in dashboards but do not actually predict whether the commercialization strategy is working.

I managed hundreds of millions in ad spend across more than 30 industries. The clients who made the best decisions were not the ones with the most sophisticated attribution models. They were the ones who had a clear theory of how their marketing was supposed to work and who used data to test that theory rather than to generate post-hoc justifications for decisions already made.

A commercialization strategy should include, from the outset, a written statement of the assumptions you are making and the signals that would tell you those assumptions are wrong. That is not pessimism. It is intellectual honesty, and it is what separates organisations that learn from launches from those that repeat the same mistakes at scale.

Growth Hacking Is Not a Commercialization Strategy

A word on growth hacking, since it tends to surface in any conversation about commercialization. There are legitimate tactical insights in the growth hacking literature. CrazyEgg’s overview of growth hacking principles and Semrush’s documented examples both contain useful case studies of companies that found creative, low-cost ways to acquire customers early. Dropbox’s referral programme is the canonical example. Airbnb’s Craigslist integration is another.

But growth hacking is a set of tactics, not a strategy. It answers “how do we acquire customers cheaply?” not “why will customers choose us over alternatives, at what price, through which channels, and with what expectation of long-term value?” Those are different questions. Conflating them produces organisations that are good at cheap acquisition and poor at building durable competitive positions.

The best commercialization strategies I have seen are not clever. They are clear. They make a specific argument about a specific market opportunity, they sequence the decisions logically, they allocate resources in proportion to strategic priority rather than organisational politics, and they build in honest checkpoints rather than vanity milestones. That is not exciting. But it is what works.

If you are building or revisiting a go-to-market approach and want to think more broadly about the strategic frameworks that sit around commercialization, the Go-To-Market and Growth Strategy hub covers adjacent topics including positioning, channel strategy, and growth model design in more depth.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions